INVESCO Ltd (IVZ)
28.50
+1.47 (5.44%)
NYSE· Last Trade: Jul 9th, 1:33 PM EDT
Dividend stocks have enjoyed a strong first half of 2026. Conditions still look favorable, which could propel these three ETFs in particular.
Via The Motley Fool · July 9, 2026
The Invesco QQQ Trust is a top ETF to buy on the tech dip.
Via The Motley Fool · July 9, 2026
PJP delivered stronger 5-year returns with lower volatility, while FBT offers broader biotech exposure at a slightly cheaper cost.
Via The Motley Fool · July 8, 2026
IBBQ offers lower costs and broader diversification, while XPH delivered stronger 1-year returns with less volatility.
Via The Motley Fool · July 8, 2026
This ETF gives investors a smarter way to think about growth and risk.
Via The Motley Fool · July 8, 2026
SpaceX's valuation is being tested now that public markets have digested its IPO.
Via The Motley Fool · July 8, 2026
SpaceX is already in some indexes.
Via The Motley Fool · July 7, 2026
SpaceX just joined the Nasdaq-100. Should you change your ETF exposure?
Via The Motley Fool · July 7, 2026
Dukes' sale was non-discretionary. She retains ~290,000 shares valued at $8.1 million.
Via The Motley Fool · July 7, 2026
Over the next several years, more and more 401(k) accounts will likely have exposure to SpaceX.
Via The Motley Fool · July 7, 2026
QQQ delivered better returns over the past five years, but also suffered a higher maximum drawdown. VOO offers lower fees and a higher dividend for more conservative investors.
Via The Motley Fool · July 7, 2026
SpaceX is joining the Nasdaq-100 this week, giving Invesco QQQ Trust investors indirect exposure to the stock.
Via The Motley Fool · July 7, 2026
As major indexes add SpaceX, you may already have a small amount of the space stock in your portfolio.
Via The Motley Fool · July 6, 2026
QQQ has dominated the past decade, while IWM is still waiting for its turn. Here is how to decide which one belongs in your portfolio.
Via The Motley Fool · July 6, 2026
SpaceX will be the first mega-IPO stock to join the Nasdaq-100 under its new fast-track entry rules.
Via The Motley Fool · July 6, 2026
RZG delivered stronger 1-year returns at 39.70%, but IJT's lower 0.18% expense ratio and $8.3B in assets offer cost advantages for long-term investors.
Via The Motley Fool · July 6, 2026
Invesco NASDAQ 100 ETF (NASDAQ:QQQM) has outperformed the market over the past 5 years by 3.53% on an annualized basis producing an average annual return of 15.0%. Currently, Invesco NASDAQ 100 ETF has a market
Via Benzinga · July 6, 2026
If your ETF tracks this index, it will buy shares of SpaceX.
Via The Motley Fool · July 6, 2026
SpaceX is joining the widely followed Nasdaq-100 Index, and that could provide a short-term jolt to its shares.
Via The Motley Fool · July 6, 2026
History isn't on the side of investors hoping to score a quick profit from SpaceX's inclusion in the Nasdaq-100.
Via The Motley Fool · July 6, 2026
You can't know the one thing you need to know about timing the market.
Via The Motley Fool · July 5, 2026
Compare the portfolio concentration, risk profiles, and long-term growth of these two pharma ETFs.
Via The Motley Fool · July 5, 2026
The Vanguard S&P 500 ETF (VOO) and the Invesco QQQ ETF (QQQ) can both serve as long-term holdings. But one is clearly better suited than the other.
Via The Motley Fool · July 5, 2026
After a stellar performance, investors are trying to figure out if this popular exchange-traded fund is worthy of their capital.
Via The Motley Fool · July 5, 2026
Compare portfolio concentration, risk profiles, and long-term growth as these two pharma ETFs take different approaches to capturing sector opportunity.
Via The Motley Fool · July 4, 2026